1h Free Analyst Time
The clinical trial imaging market is forecasted to grow by USD 551.3 million during 2023-2028, accelerating at a CAGR of 7.5% during the forecast period. The report on the clinical trial imaging market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing investment in drug discovery, high growth in emerging countries, and adoption of imaging in clinical trials for cancer therapies.
The clinical trial imaging market is segmented as below:
By Modality
- Computed tomography
- Magnetic resonance imaging
- Ultrasound
- Positron emission tomography
- Others
By End-user
- Contract research organization
- Pharmaceutical and biotechnology companies
- Research and academic institutes
- Medical device manufacturers
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the clinical trial imaging market covers the following areas:
- Clinical Trial Imaging Market sizing
- Clinical Trial Imaging Market forecast
- Clinical Trial Imaging Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Modality
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global clinical trial imaging market: Alimentiv Inc, ARANZ Medical Ltd, Aster Medical Imaging LLC, Charles River Laboratories International Inc., Clario, ICON plc, Image Core Lab Pvt Ltd, IXICO plc, Median Technologies SA, Medidata, Medpace Holdings Inc., Navitas Life Sciences, Octalsoft, QMENTA Imaging SL, QUANTIFICARE, THIRONA, Vista Diagnostics Ltd, Voiant, WCG Clinical Inc., and Yunu, Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is partnerships and collaborations."
According to the report, one of the major drivers for this market is the growing investment in drug discovery.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alimentiv Inc
- ARANZ Medical Ltd
- Aster Medical Imaging LLC
- Charles River Laboratories International Inc.
- Clario
- ICON plc
- Image Core Lab Pvt Ltd
- IXICO plc
- Median Technologies SA
- Medidata
- Medpace Holdings Inc.
- Navitas Life Sciences
- Octalsoft
- QMENTA Imaging SL
- QUANTIFICARE
- THIRONA
- Vista Diagnostics Ltd
- Voiant
- WCG Clinical Inc.
- Yunu Inc.
